Cheung E, Kwong V, Ng K, Lui M, Li V, Lee R
Cancers (Basel). 2025; 17(3).
PMID: 39941890
PMC: 11816590.
DOI: 10.3390/cancers17030523.
Hendriks L, Remon J, Faivre-Finn C, Garassino M, Heymach J, Kerr K
Nat Rev Dis Primers. 2024; 10(1):71.
PMID: 39327441
DOI: 10.1038/s41572-024-00551-9.
Pires D, Chaves L, Dantas Cardoso C, Faria L, Rodrigues Campos S, da Silva M
PLoS One. 2024; 19(9):e0308106.
PMID: 39259749
PMC: 11389911.
DOI: 10.1371/journal.pone.0308106.
Duer E, Yang H, Robinson S, Grigore B, Sandercock J, Snowsill T
Diagn Progn Res. 2023; 7(1):26.
PMID: 38072977
PMC: 10712083.
DOI: 10.1186/s41512-023-00162-0.
Liu Y, Feng Z, Fan Z, Zhang Y, Li C, Liu X
Front Oncol. 2023; 13:1203320.
PMID: 37534249
PMC: 10392917.
DOI: 10.3389/fonc.2023.1203320.
Important steps towards a big change for lung health: a joint approach by the European Respiratory Society, the European Society of Radiology and their partners to facilitate implementation of the European Union's new recommendations on lung cancer....
Ward B, Koziar Vasakova M, Cordeiro C, Yorgancioglu A, Chorostowska-Wynimko J, Blum T
ERJ Open Res. 2023; 9(3).
PMID: 37228272
PMC: 10204812.
DOI: 10.1183/23120541.00026-2023.
Lung Cancer Screening With Low-Dose Computed Tomography.
Reck M, Dettmer S, Kauczor H, Kaaks R, Reinmuth N, Vogel-Claussen J
Dtsch Arztebl Int. 2023; 120(23):387-392.
PMID: 37198995
PMC: 10433361.
DOI: 10.3238/arztebl.m2023.0099.
The 50-Year Journey of Lung Cancer Screening: A Narrative Review.
Parekh A, Deokar K, Verma M, Singhal S, Bhatt M, Katoch C
Cureus. 2022; 14(9):e29381.
PMID: 36304365
PMC: 9585290.
DOI: 10.7759/cureus.29381.
SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection.
Wang Q, Gumus Z, Colarossi C, Memeo L, Wang X, Kong C
J Thorac Oncol. 2022; 18(1):31-46.
PMID: 36243387
PMC: 10797993.
DOI: 10.1016/j.jtho.2022.10.002.
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.
Bonney A, Malouf R, Marchal C, Manners D, Fong K, Marshall H
Cochrane Database Syst Rev. 2022; 8:CD013829.
PMID: 35921047
PMC: 9347663.
DOI: 10.1002/14651858.CD013829.pub2.
The challenges of implementing low-dose computed tomography for lung cancer screening in low- and middle-income countries.
Saul E, Guerra R, Edelman Saul M, Lopes da Silva L, Aleixo G, Matuda R
Nat Cancer. 2022; 1(12):1140-1152.
PMID: 35121933
DOI: 10.1038/s43018-020-00142-z.
Generalizability and Transportability of the National Lung Screening Trial Data: Extending Trial Results to Different Populations.
Inoue K, Hsu W, Arah O, Prosper A, Aberle D, Bui A
Cancer Epidemiol Biomarkers Prev. 2021; 30(12):2227-2234.
PMID: 34548326
PMC: 8643314.
DOI: 10.1158/1055-9965.EPI-21-0585.
Does lung cancer screening with low-dose computerized tomography improve survival?.
Manuel L, Fong L, Ly T, Meredith G
Interact Cardiovasc Thorac Surg. 2021; 33(5):741-745.
PMID: 34297834
PMC: 8691711.
DOI: 10.1093/icvts/ivab154.
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
Mazzone P, Silvestri G, Souter L, Caverly T, Kanne J, Katki H
Chest. 2021; 160(5):e427-e494.
PMID: 34270968
PMC: 8727886.
DOI: 10.1016/j.chest.2021.06.063.
Executive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report.
Mazzone P, Silvestri G, Souter L, Caverly T, Kanne J, Katki H
Chest. 2021; 160(5):1959-1980.
PMID: 34270965
PMC: 8727851.
DOI: 10.1016/j.chest.2021.07.003.
Lung Cancer Screening with Low-Dose CT in Smokers: A Systematic Review and Meta-Analysis.
Hunger T, Wanka-Pail E, Brix G, Griebel J
Diagnostics (Basel). 2021; 11(6).
PMID: 34198856
PMC: 8228723.
DOI: 10.3390/diagnostics11061040.
Cancer-Specific Mortality, All-Cause Mortality, and Overdiagnosis in Lung Cancer Screening Trials: A Meta-Analysis.
Ebell M, Bentivegna M, Hulme C
Ann Fam Med. 2020; 18(6):545-552.
PMID: 33168683
PMC: 7708293.
DOI: 10.1370/afm.2582.
Lung Cancer Screening with Low-Dose CT: a Meta-Analysis.
Hoffman R, Atallah R, Struble R, Badgett R
J Gen Intern Med. 2020; 35(10):3015-3025.
PMID: 32583338
PMC: 7573097.
DOI: 10.1007/s11606-020-05951-7.
Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis.
Huang K, Wang S, Lu W, Chang Y, Su J, Lu Y
BMC Pulm Med. 2019; 19(1):126.
PMID: 31296196
PMC: 6625016.
DOI: 10.1186/s12890-019-0883-x.
Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
J Thorac Oncol. 2019; 14(10):1732-1742.
PMID: 31260833
PMC: 6764895.
DOI: 10.1016/j.jtho.2019.05.044.